Agencia Española de Medicamentos y Productos Sanitarios (AEMPS)
CIMA — Centro de Información de Medicamentos · Spain
- Updated
- Not provided for this source record
- Synchronized
- Oct 2, 2026
Medicine · Spain
AMOXICILINA/ACIDO CLAVULANICO TEVAGEN 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG
Suspension
Home Med Cabinet
Updated · Agencia Española de Medicamentos y Productos Sanitarios (AEMPS) — Not provided for this source record
Synchronized
At a glance
- Active ingredient
- AMOXICILINA TRIHIDRATO — 875 mg
- CLAVULANATO POTASIO — 125 mg
- Pharmaceutical form Home Med Cabinet grouping
- Suspension
- Availability in Spain
- All 2 packs marketed
Packs
AMOXICILINA/ACIDO CLAVULANICO TEVAGEN 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG, 30 sobres
30 pcs
National code
Marketed695556Strength of this pack 875 mg
AMOXICILINA/ACIDO CLAVULANICO TEVAGEN 875 mg/125 mg POLVO PARA SUSPENSION ORAL EN SOBRES EFG, 20 sobres
20 pcs
National code
Marketed695557Strength of this pack 875 mg
“Marketed” means the authority records the pack as placed on the market. It is not a statement about pharmacy stock.
Official documents
Documents open on the authority’s own site. Home Med Cabinet links to them and hosts no copy.
- Official
Opens on the authority’s own site
- Official
Summary of product characteristics
Opens on the authority’s own site
Registration
- Registration number
- 65422Official data
- Marketing authorisation holder
- TEVA PHARMA S.L.U.Official data
- Authorised
- Jun 10, 2003Official data
- Authority form code
- 9Official data
Classification
ATC classification is not published here yet
Publication rights for ATC codes and labels are still under review, and no classification is inferred for this record.